Klaria Pharma announces extraordinary shareholder meeting

• Klaria Pharma Holding will hold an extraordinary general meeting on Oct. 5, 2026, in Sweden.
• Shareholders will vote on resolutions proposed by the board.
• The board’s full proposals are scheduled for publication by Sept. 21, 2026, on the company website.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klaria Pharma Holding AB published the original content used to generate this news brief via Cision (Ref. ID: 202609140658BITN____UKPR__EN_20260914-BIT-9979-0) on September 14, 2026, and is solely responsible for the information contained therein.